Pivotal bioVenture Partners Fund I L.P. 13D and 13G filings for Akouos, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-25 4:07 pm Unchanged | 2022-08-25 | 13G | Akouos, Inc. AKUS | Pivotal bioVenture Partners Fund I L.P. | 1,794,088 4.900% | 0 (Unchanged) | Filing |
| 2022-02-14 09:18 am Unchanged | 2021-12-31 | 13G | Akouos, Inc. AKUS | Pivotal bioVenture Partners Fund I L.P. | 1,794,088 5.200% | 0 (Unchanged) | Filing |
| 2021-02-09 5:02 pm Unchanged | 2020-12-31 | 13G | Akouos, Inc. AKUS | Pivotal bioVenture Partners Fund I L.P. | 1,794,088 5.200% | 0 (Unchanged) | Filing |
| 2020-07-10 09:26 am Purchase | 2020-07-02 | 13D | Akouos, Inc. AKUS | Pivotal bioVenture Partners Fund I L.P. | 1,794,088 5.500% | 1,794,088 (New Position) | Filing |